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Evaluation of Rapid Syphilis Testing Using the
Syphilis Health Check in Florida, 2015–2016
_______________________________________________________________________________
Jennifer Richards, MPH, DrPH student; James Matthias, MPH; Charlotte Baker, DrPH,
MPH, CPH; Craig Wilson; Thomas A Peterman, MD, MSC; C Perry Brown, DrPH, MSPH;
Matthew Dutton, PhD; Yussif Dokurugu, DrPH, MPH
________________________________________________________________________________
ABSTRACT
The Syphilis Health Check (SHC) had low estimated specificity (91.5%) in one Florida county. We investigated use of
SHC by a range of Florida publicly-funded programs between 2015 and 2016 to estimate specificity, positive predictive
value (PPV), field staff acceptance, and impacts on programmatic outcomes. All reported SHC results were extracted
from routinely collected program data. Field staff were surveyed about SHC’s utility. Analyses investigated differences
between SHC and traditional syphilis testing outcomes. Of 3,630 SHC results reported, 442 were reactive; 92 (20.8%)
had prior diagnoses of syphilis; 7 (1.6%) had no further testing. Of the remaining 343; 158 (46.0%) were confirmed
cases, 168 (49.0%) were considered false-positive, and 17 (5.0%) were not cases but not clearly false-positive. Estimated
specificity of SHC was 95.0%. Overall, 48.5% of positives became confirmed cases (PPV). PPV varied according to
prevalence of syphilis in populations tested. Staff (90%) thought SHC helped identify new cases but expressed concern
regarding discordance between reactive SHC and lab-based testing. Programmatic outcomes assessment showed shorter
time to treatment and increased numbers of partners tested for the SHC group; these enhanced outcomes may better
mitigate the spread of syphilis compared to traditional syphilis testing alone, but more research is needed.
Richards, J., Matthias, J., Baker, C., Wilson, C., Peterman, T.A., Brown, C.P., Dutton, M., & Dokurugu, Y. (2019).
Evaluation of rapid syphilis testing using the syphilis health check in Florida, 2015–2016. Florida Public Health
Review, 16, 106-119.
____________________________________________________________________________________________
BACKGROUND
The U.S. Food and Drug Administration granted
the first-ever Clinical Laboratory Improvement
Amendments waiver for a rapid treponemal syphilis
screening test, Syphilis Health Check, in December
2014 (FDA, 2014). Accurately identifying new cases
of syphilis, administering timely treatment, and
securing timely partner notification for testing and
treatment are cornerstones of successful public health
interventions to control the spread of syphilis.
The SHC may facilitate these interventions, but
very few studies have investigated its performance in
the field. One small cohort study found that sensitivity
was 71.4% and specificity was 91.5%, significantly
lower than the >98% specificity reported for SHC
(Matthias et al., 2016). Findings from a larger United
States cohort study using 2014 – 2016 data to
investigate the performance of SHC showed that
sensitivity ranged from 88.7% to 95.7% and
specificity ranged from 93.1% to 93.2%, depending on
the method of confirmatory test result consensus used
(Pereira et al., 2018). Other studies have found mixed
results with a range of sensitivity (61.1% to 92.0%),
specificity (92.7% to 99.6%), and positive predictive
Florida Public Health Review, 2019; 16, 106-119.
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value (9.4% to 97.5%) (Jafari et al., 2013; Seña,
White, & Sparling, 2010; Toskin et al., 2017).
Few studies have assessed the acceptability of the
SHC among healthcare workers and patients (Ansbro
et al., 2015; Swartzendruber, Steiner, Adler, Kamb, &
Newman, 2015), and none have been from the United
States. A rapid point of care test could reduce clinic
waiting time, allow same-day treatment, facilitate
outreach testing, and allow substitution of finger-stick
for venipuncture (Ansbro et al., 2015; Swartzendruber
et al., 2015). Faster identification of new syphilis cases
could decrease time to treatment and facilitate partner
treatment.
Purpose
Florida has multiple syphilis testing sites across the
state and routinely captures testing and case
management information, including time to treatment
and numbers of partners named, tested, infected, and
treated. We aimed to describe the results of SHC
testing in Florida after a state-wide implementation
and the impact on programmatic outcomes. Moreover,
we surveyed the staff that used SHC to identify
benefits and challenges to using it in the field.
Page 106
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METHODS
Data Extraction and Study Population
All records for adults tested with SHC from
08/01/2015 through 12/31/2016 were extracted, deidentified, and compiled. The SHC was performed by
health department staff who had been trained in
administering the SHC. Test settings varied based on
program needs. Data included syphilis testing
location, test type, test results, case/non-case
determination, treatment, and partner services
outcomes. We excluded persons who required testing
for congenital syphilis or neurosyphilis, as the SHC
test is not appropriate for determining these types of
syphilis. This was a program evaluation of standard
routine public health practices using de-identified
programmatic data. Thus, it was determined not to be
human subjects research.
SHC Reactivity Rate Determination
All 67 Florida health departments were given the
opportunity to receive SHC kits for rapid syphilis
testing free of charge. Each health department selfselected whether to use the SHC at its site or not. If a
health department did request SHC kits to use, the only
stipulation was that the health department had to report
all SHC test results to the health department of the
county in which the patient resides. Training of field
staff for use of the SHC was provided by the SHC
distributor. All tests reported in this study were done
by health departments. A total of 35 Florida counties
conducted SHC testing. For inter-county comparison,
data was stratified by volume of SHC tests given for
the top 11 SHC-using counties and combined for the
small volume remaining in the other 24 counties. The
top 11 counties, in order of greatest number of SHC
tests conducted to the least, were Orange, MiamiDade, Escambia, Lee, Alachua, Polk, Duval, Leon,
Hillsborough, Palm Beach, and Brevard.
The performance of the SHC was investigated at
both statewide and county levels. Variables of interest
were SHC test result status (positive or negative),
agreement or discordance between SHC results and
traditional testing (non-treponemal and/or treponemal)
results, new syphilis cases identified from SHC
testing, and new syphilis cases treated as the result of
positive SHC test results.
We excluded from the analyses any SHC test
results that were done on persons with a history of past
syphilis or when there were no associated
confirmatory test results. The prevalence of syphilis
among persons appropriately tested was estimated as
the number of new syphilis cases reported divided by
the number of persons tested. The Council for State
and Territorial Epidemiologists (CSTE) case
definition for reported syphilis cases was used to
determine new cases.(Sosa, 2017) Specific to this
Florida Public Health Review, 2019; 16, 106-119.
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study, new cases were assessed and classified by local
program staff. For this evaluation, SHC reactive tests
without both a reactive treponemal and nontreponemal test or a diagnosis of primary syphilis by a
provider were considered inconclusive. Positive
predictive value (PPV) was calculated after excluding
persons with inconclusive results on additional testing.
Thus, PPV was the new cases divided by the sum of
the new cases plus the false positives, times 100.
Specificity was estimated by considering all negative
SHC to be true negatives. No false negative SHC were
identified because persons who tested negative on the
SHC were not retested. The specificity is the number
of true negatives divided by the sum of the true
negatives plus the false positives, times 100.
Programmatic Outcomes Assessment Comparing SHC
with Traditional Syphilis Testing
In order to identify programmatic benefits of the
SHC, we conducted analyses comparing cases
identified using the SHC administered by health
department staff with cases identified at public health
departments using traditional syphilis testing in the 11
Florida counties that did the most SHC testing during
the defined study period for 2015 and 2016. Treatment
data were collected by health department staff from
syphilis investigations conducted by healthcare
providers. Timeliness of treatment was calculated by
subtracting the recorded date of treatment from the
date of specimen collection. The outcome variables
were timeliness of treatment, number of named
partners, number of named partners tested, number of
named partners infected, and number of infected
partners treated (see Variables of Interest, Appendix
1).
Survey Interviews of Field Staff
Field staff interviews were conducted from
09/27/2017 through 10/19/2017 using a 27-question
survey instrument to assess the value of the SHC as a
screening test and its effectiveness as a tool to prevent
the spread of syphilis (see Survey Instrument,
Appendix 2). Survey participants were not chosen at
random, rather they were chosen based on expertise
with the SHC. Participants consisted of one program
manager and those field staff who had the most
experience administering the SHC test as identified by
the Florida Department of Health STD program. The
roles served by these field staff included syphilis
testing, supervising staff who conduct syphilis testing,
and those involved in follow-up partner services. Field
staff participating in the survey were representative of
the top 11 SHC-using Florida counties: Orange,
Miami-Dade, Escambia, Lee, Alachua, Polk, Duval,
Leon, Hillsborough, Palm Beach, and Brevard. For
consistency, all surveys were conducted by one
research team member via telephone interview.
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Data Analysis
Statistical analyses were done using SAS 9.4 (Cary,
NC) and OpenEpi.com (Dean, Sullivan, & Soe, 2011).
Chi Square tests were used to determine statistically
significant differences between groups. Generalized
Linear Models (GLM) were used to determine whether
statistically significant differences existed between the
means of programmatic outcomes for the SHC Testing
Group and the Traditional Testing Group.
RESULTS
SHC Reactivity Rate Determination
For 08/01/2015 through 12/31/2016, there were
3630 SHC tests reported, 442 (12.0%) were positive,
3168 (87.0%) were negative, and 20 (1.0%) were
inconclusive. Of the 442 positive SHC results, 92
(20.8%) had a prior diagnosis of syphilis (even though
a screening tool was used to minimize SHC testing in
this group), 7 (1.6%) had missing information
regarding prior diagnosis of syphilis or had no further
confirmatory testing, leaving 343 (77.6%) who had no
prior diagnosis of syphilis and had further testing. Of
these 343, 158 (46.0%) were considered true positives
based on non-treponemal reactive rapid plasma reagin
(RPR) and treponemal (primarily treponemal enzyme
immunoassays [EIA]) testing (157) or a negative RPR
with a reactive treponemal test and a lesion consistent
with primary syphilis (Figure 1). Treatment was
documented for 157 (99.4%) of the 158 new cases.
There were 168 (49.0%) false positives that were not
reported as new cases and had negative results on the
RPR (138), treponemal test, or both (29). Finally, 17
(5.0%) of the 343 with reactive SHC were considered
inconclusive because they were not reported as a new
case of syphilis but had reactive results on the RPR (7),
treponemal test, or had the combination of reactive
treponemal test /negative RPR (9). The prevalence of
new syphilis in the population tested (after removing
those with inconclusive SHC results, prior syphilis, or
no further testing) was 4.5% (158/[3630-20-92-7]).
Specificity was estimated to be 95% using the false
positives (168) and all 3168 who tested negative on
SHC (3168/[168+3168], x 100). The PPV was
estimated from the true and false positives to be 48.5%
(158/[158+168]) (Table 1).
The largest number of SHCs were done in Orange
County, followed by Miami-Dade, Escambia, Lee,
Alachua, Polk, Duval, Leon, Hillsborough, Palm
Beach, and Brevard. These counties accounted for
approximately 93.0% of all SHC testing conducted
and approximately 90.0% of all new cases of syphilis
that were identified using the SHC test in Florida
during the time period. The statewide prevalence of
newly identified syphilis (those cases found using the
SHC test) in the populations tested was estimated to be
4.5% (range of 0.4% to 28.2% in all SHC using
Florida Public Health Review, 2019; 16, 106-119.

Published by UNF Digital Commons, 2019

counties). Statewide, 48.5% of persons with a positive
SHC had newly diagnosed syphilis (the positive
predictive value). By county, this ranged from 8.0% to
100%, depending on the prevalence of syphilis among
those tested, and was lowest in the two highest SHC
volume counties. Per county, the specificity ranged
from 90.1% to 100% among the 11 most SHC-using
counties (Table 1).
Programmatic Outcomes Assessment Comparing SHC
with Traditional Syphilis Testing
The sample size of syphilis cases used in the
analyses of programmatic outcomes was n=1644 and
included those who: (a) were tested for syphilis using
SHC or traditional testing during the study period, (b)
were from the top 11 SHC-using Florida counties, (c)
had no prior diagnosis of syphilis, and (d) had public
initial lab ordering providers. Of these 1644 cases, 93
were from the SHC testing group and 1551 were from
the traditional testing group. In the SHC testing group,
all 93 cases were treated. In the traditional testing
group, 37 of the 1551 cases (2.4%) were not treated or
were otherwise lost to follow-up.
Timeliness of treatment. Persons tested with SHC were
more likely to receive prompt treatment than persons
from the traditional testing group [same day (RR =
1.88; 95% CI, 1.54-2.30), 7 days or less (RR = 1.63;
95% CI, 1.44-1.84), 14 days or less (RR = 1.19; 95%
CI, 1.10-1.28), and 30 days or less (RR = 1.06; 95%
CI, 1.03-1.10)]. The average time to treatment among
those treated was 7.3 days for the SHC group versus
13.0 days for the traditional testing group (F=3.55,
p=0.06) (Table 2).
Partner Elicitation, Testing, and Treatment. Among
new cases, patients tested with the SHC were more
likely to name partners than patients who had
traditional testing (RR = 1.44; 95% CI, 1.27-1.63) and
they named a higher average number of partners (1.3
compared to 0.8 partners) (F=16.79, p<.0001) (Table
2). Patients who had SHC testing were more likely to
have at least one named partner tested than patients
from the traditional testing group (RR = 1.45; 95% CI,
1.23-1.72) and they had a higher average number of
named partners tested (0.9 partners compared to 0.6
partners) (F=20.35, p<.0001) (Table 2). The SHC
testing group was more likely to have named partners
identified as infected than was the traditional testing
group (RR = 2.34; 95% CI, 1.82-3.01) and had a
higher average number of named partners identified as
infected (0.5 compared to 0.2 partners infected)
(F=40.20, p<.0001), even when controlling for those
who named at least one partner (0.8 compared to 0.5)
(F=19.13, p <.0001) (Table 2). The SHC testing group
was more likely to have infected partners subsequently
treated than was the traditional testing group (RR =
Page 108
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2.29; 95% CI, 1.77-2.96) and had a higher average
number of named infected partners treated (0.5
compared to 0.2) (F=37.58, p<.0001) (Table 2).
Survey Interviews of Field Staff
A total of 20 field staff surveys were conducted.
These field staff included one test administrator and
one program manager from each of the high-volume
SHC-using programs (with one of the test
administrators and one of the program managers
representing two of the high-volume counties that are
adjacent to each other). The 20 survey participants
reported that the training they received from the SHC
distributor for using the SHC test prepared them to
confidently administer the test. Most said the SHC test
was easy to use (15/20), test results were easy to read
(16/20), and that they had confidence in the accuracy
of the results (12/20). Strengths of the SHC included:
(a) highly appropriate to use in outreach settings (6/20,
30%), and (b) quick results were appreciated by staff
and patients (8/20, 40%). Respondents described
twenty-two examples in which the SHC test was
particularly helpful to field staff and/or patients and
are elucidated here: (a) confirming syphilis in the
presence of symptoms (2/20), (b) quickly putting
patients’ minds at ease when SHC results were
negative or making patients aware of the need for
further testing when SHC results were positive (3/20),
(c) testing people who preferred a finger-stick or were
afraid of needles (16/20), and (d) quickly identifying
an infected pregnant patient who was HIV positive
(1/20).
Settings that survey respondents thought were most
appropriate for using the SHC test were health
department clinics, outreach sites, physician’s offices,
emergency rooms, community-based organizations,
jails, STD clinics, and any sites that offer free services.
Most respondents thought the SHC test was a
beneficial addition to traditional syphilis testing
(16/20). When asked about the percentage of clients
who had a difficult time understanding what a positive
SHC test result meant, the answers varied widely from
0.0% to 80.0%, with the majority being 10.0% or less.
The respondents further stated that this was “about the
same” amount as clients who also had difficulty
understanding results from traditional syphilis testing.
The weaknesses reported for the SHC test were that
test kits expired too quickly (2/20) and that the pipet
included in the test kit was flimsy, making it difficult
to get a blood sample (7/20). The most common
complaint about the SHC test was field staff were
concerned there may have been too many “false
positive” results (14/20).

Florida Public Health Review, 2019; 16, 106-119.
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Most respondents said they did not notify named
partners of clients with positive SHC test results until
they have the confirmatory test results back (14/20).
Replies from the 20 respondents about beginning
treatment for syphilis, based on positive test results
from the SHC alone, were mixed; five were “highly
likely” to begin treatment, five were “likely” to begin
treatment, one was “neutral,” three were “unlikely,”
and six were “very unlikely.” Those who were “highly
likely” or “likely” to begin treatment reserved this
only for clients who also had symptoms of syphilis or
had a confirmed syphilis exposure.
Most respondents said that positive SHC test results
presented no more of a challenge for counseling or
administering treatment than positive results from
traditional syphilis testing (17/20). Most respondents
also said that the quick results from the SHC test
provided a better service than traditional testing for
clients in settings other than the health clinics (17/20).
For syphilis testing in settings other than the health
clinic (such as outreach sites), most respondents said
they prefer to use the SHC test because a larger volume
of testing can be done, and it helps to mitigate the
spread of syphilis, especially in jails, where there is a
readily available audience for testing participation
(13/20). Respondents’ opinions varied regarding the
use of the SHC test in the health clinic settings; five
preferred using the SHC test alone, four preferred
using traditional testing alone, six preferred using both
the SHC test and traditional testing together, three had
no preference, and two were neutral.
DISCUSSION
Using data collected from testing in a wide variety
of settings in Florida, we estimate the specificity of the
SHC was 95.0%, as in many cases the SHC was
compared against a non-treponemal result. Although
the specificity was fairly consistent in the 11 different
counties studied, the proportion of persons with
positive tests who were diagnosed as having syphilis
(predictive value of a positive test) varied, mostly due
to differences in the prevalence of syphilis among
those tested (0.4% to 28.2%). Compared to the
traditional testing group, the SHC testing group had
more timely treatment, more partners named, and
more partners identified as infected. These enhanced
outcomes may be due to quick SHC test results
allowing for more accurate recall in naming partners,
as well as enabling Disease Intervention Specialists
(DIS) to promptly notify these named partners (Hoots
et al., 2014; Rudy et al., 2012).
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Table 1. Syphilis Health Check (SHC) Tests Conducted, those Leading to New Syphilis Casesa, and
Estimated Specificity by County

County

Total
SHCb
Tests
Conducted

1 - Orange
2 - MiamiDade
3Escambia
4 - Lee
5 - Alachua
6 - Polk
7 - Duval
8 - Leon
9Hillsborough
10 - Palm
Beach
11 - Brevard
All other
testing
counties (n
=24)
Total for
entire state
of Florida
a

Estimated
Specificitye

Total
Positivesac
SHCb
936
72
530
28

New
Syphilis
Casesa
20
2

52
23

27.8%
8.0%

94.7%
95.8%

False
Positivesd

471

401

60

32

26

55.2%

93.9%

450
202
162
130
100
95

426
179
150
78
90
64

22
17
8
39
9
29

5
4
6
33
1
22

17
13
1
2
8
7

22.7%
23.5%
85.7%
94.3%
11.1%
75.9%

96.2%
93.2%
99.3%
97.5%
91.8%
90.1%

87

73

12

3

7

30.0%

91.3%

75

41

15

14

0

100%

100%

248

200

32

16

12

57.1%

94.3%

3630

3168

343

158

168

48.5%

95.0%

Syphilis Health Check

Excludes those with inconclusive SHC (20), prior syphilis (92), or no further testing after a positive test (7)

d
e

Positive
Predictive
Value (PPV)

Total Reactive SHCb

For those who had no prior diagnosis of syphilis

b
c

1042
568

Total
Negative
SHCb

Excludes those with inconclusive test results (17)

Estimated Specificity = True Negatives/(True Negatives + False Positives)

Florida Public Health Review, 2019; 16, 106-119.
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Table 2. Comparison of Group Averages for Programmatic Outcomes Between the SHCa Testing Group
and the Traditional Testing Group
Programmatic Outcome
Time to Treatment Among Those Who Were
Treated, (days, mean)
Named Partners, (mean)
Partners Tested, (mean)
Named Partners Tested Among Those Who Named
Partners, (mean)
Partners Infected, (mean)
Partners Infected Among Those Who Named
Partners, (mean)
Infected Partners Treated, (mean)
a
Syphilis Health Check

SHCa Testing
Group
n=93b
7.3

Traditional Testing
Group
n=1551b
13.0 (n=1514)

1.3
0.9
1.3 (n=70)

0.8
0.6
1.1 (n=811)

<0.0001
<0.0001
0.0632

0.5
0.8 (n=58)

0.2
0.5 (n=665)

<0.0001
<0.0001

0.5

0.2

<0.0001

p-value
0.0597

b

This sub-group includes only the top 11 SHC using counties, subjects with no prior diagnosis of syphilis, and only
those subjects who had a public initial lab ordering provider

Figure 1. Flow Chart for Syphilis Health Check Positive Results Leading to New Syphilis Cases
A flow chart showing SHCa positive test results leading to new syphilis cases from 08/01/2015 through
12/31/2016.
a

Syphilis Health Check, bDiagnosis, cRapid Plasma Reagin, dOutlier case conclusively identified as primary
syphilis

Florida Public Health Review, 2019; 16, 106-119.
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Additionally, a greater sense of urgency for both
patient and practitioner may exist when SHC results
are positive in the presence of signs and symptoms
and/or a known syphilis exposure. This scenario might
create expediency for an intervention conversation at
this initial encounter to educate the patient and
possibly administer treatment. Our findings suggest
the SHC could improve syphilis control efforts,
however the administration and selection for SHC
testing was not randomly assigned and outcomes were
assessed against a small sample size of newly detected
cases. Going forward, a more rigorous evaluation
could help determine if the SHC test truly does
improve these outcomes.
Our estimated specificity is higher than the
specificity estimated in a previous investigation in
Florida (Matthias et al., 2016). A low specificity could
be a serious deterrent to using the SHC in low
prevalence settings. However, one study concluded
that even in low prevalence settings, screening with
rapid syphilis testing remains cost-effective and less
expensive than use of the RPR (Mallma et al., 2016).
Before
implementing
the
SHC,
program
administrators should discern the potential value of the
test, based on the specific characteristics of their
individual programs. Given the relatively stable
specificity, but highly variable PPV, the benefits of the
SHC will depend on the population tested.
Field staff liked the SHC test, with a majority citing
practicality for use by non-laboratory health care
workers, flexibility for use in non-traditional settings,
and faster test results that allowed quicker
identification and treatment of new syphilis cases.
They also believed that use of the SHC test could help
reduce the spread of syphilis. Field staff also reported
concerns about test kits expiring too quickly,
challenges in sample collection, and accuracy of
results. This information helps to fill in previously
recognized gaps in understanding of the performance,
usefulness, and limitations of the SHC (Seña et al.,
2010).
This study had several limitations. The sensitivity
of the SHC test could not be determined because
specimens with negative SHC results were not retested with other tests to see if any infections were
missed. The estimated specificity and “false positives”
compared results from a treponemal-based rapid test
to, in many cases, only a non-treponemal test.
Although these persons would be unlikely to have
syphilis, some probably had treponemal antibody due
to a previous infection. These issues may limit the
confidence in the specificity estimate. Information
from the survey interviews of field staff may be unique
to Florida’s syphilis prevention program, and therefore
may not be generalizable to other programs.
Florida Public Health Review, 2019; 16, 106-119.
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Implications for Public Health Practice
The SHC test appears to be an effective screening
tool that provides rapid and reliable test results,
especially in the presence of symptoms, that may
facilitate same-day treatment or shorter overall time to
treatment. The rapid results may enhance timely
partner notification by reducing delays in new case
identification and reporting, as well as facilitate
successful partner services interactions. In addition, it
was highly acceptable to both healthcare workers and
patients. Our findings about the impact of the SHC on
these important outcomes are promising. Further
research is needed to continue to define the benefits
and limitations of this new test.
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Appendix 1. Variables of Interest Regarding Programmatic Outcomes
Variable Name
SHC Testing Group

Variable Type
Categorical

Traditional Testing Group

Categorical

Timeliness of Treatment

Categorical and continuous

Number of Named Partners

Categorical and continuous

Number of Named Partners
Who Were Tested

Categorical and continuous

Number of Named Partners
Who Were Infected

Categorical and continuous

Number of Named Partners
Who Were Infected and Treated

Categorical and continuous

a

Definition
New cases of syphilis identified
with the SHCa test
New cases of syphilis identified
with traditional syphilis tests
Categorical – mutually inclusive
time interval cut points:
Zero days to treatment
7 days or less to treatment
14 days or less to treatment
30 days or less to treatment
Over 30 days to treatment or no
treatment given
Continuous – time to treatment
in days
Categorical – stratified
responses as “Yes” (partners
were named) or “No” (zero
partners were named)
Continuous – numbers of
partners named
Categorical – stratified
responses as “Yes” (named
partners were tested) or “No”
(zero named partners were
tested)
Continuous – numbers of named
partners tested
Categorical – stratified
responses as “Yes” (named
partners were infected) or “No”
(zero named partners were
infected)
Continuous – numbers of named
partners infected
Categorical – stratified
responses as “Yes” (named
partners were infected and
treated) or “No” (zero named
partners were infected and
treated)
Continuous – numbers of named
partners infected and treated

This table describes the variables of interest used to analyze programmatic outcomes.
a

Syphilis Health Check
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Appendix 2.
Field Staff Questionnaire – Assessment of the Rapid Syphilis Health Check
Name of Staff Member __________________________________________
County Name __________________________________________________
Instructions:
This survey is being done to obtain the perspectives of field staff about syphilis testing using the
Rapid Syphilis Health Check (RSHC). We would like to know what you think about the
implementation of syphilis testing using the RSHC in your field setting to help determine best
practices and effectiveness of this test.
Section A.
Please complete the following questions.
1. What is your primary profession or role? (Check one response only)
□ Nurse
□ Phlebotomist
□ Disease Intervention Specialist
□ Lab Technician
□ Nurse Practitioner
□ Health Support Technician
□ Area Manager
□ STD Supervisor
□ Other ___________________________
2. What is your role in syphilis testing? (Check all that apply)
□ Management or administrative role in syphilis testing
□ Supervise staff conducting syphilis testing
□ Conduct syphilis testing
□ Provide health care services for patients who have received syphilis testing/screening
□ Teach other providers or students about syphilis testing
□ Follow-up partner services
□ Other (Specify) _______________________________________________________________
Section B.
When answering the following questions, think of the value of the RSHC as a screening test
for syphilis.
1. Did the training you received for the RSHC test prepare you to confidently administer this test
to those seeking syphilis testing?
□ Yes
□ No
□ If you answered “no”, please explain:
______________________________________________________________________________
______________________________________________________________________________
2. Would you rate the RSHC test:
□ Easy to use
□ Difficult to use
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If you answered “difficult”, please explain:
______________________________________________________________________________
______________________________________________________________________________
3. Did you experience any challenges in administering the RSHC test?
□ Yes
□ No
If you experienced any challenges, please list them here:
______________________________________________________________________________
______________________________________________________________________________
Please list any suggestions you may have to address these challenges:
______________________________________________________________________________
______________________________________________________________________________
4. Would you rate RSHC test results:
□ Easy to read/interpret
□ Difficult to read/interpret

□ Neutral

If you answered “difficult”, please explain:
______________________________________________________________________________
______________________________________________________________________________
5. Do you have confidence in the accuracy of the RSHC test results?
□ Yes
□ No
Please explain your answer, for either “Yes” or “No”:
______________________________________________________________________________
______________________________________________________________________________
6. Were there any strengths of the RSHC test as a screening test? If so, please list them:
______________________________________________________________________________
______________________________________________________________________________
7. Were there any weaknesses of the RSHC test as a screening test? If so, please list them:
______________________________________________________________________________
______________________________________________________________________________
8. Was there a situation(s) in which you found the RSHC to be particularly helpful?
□ Yes
□ No
□ Unsure/don’t know
Please explain your answer:
______________________________________________________________________________
______________________________________________________________________________
9. What settings are most appropriate for use of the RSHC test? (Check all that apply)
□ Health Department Clinic
□ Outreach site
□ Physician’s office
□ Emergency Room
□ Community-based Organization
Florida Public Health Review, 2019; 16, 106-119.
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□ Other: ______________________________________________________________________
10. Has the use of the RSHC test been a beneficial addition to traditional syphilis testing, or
would the traditional testing alone suffice?
□ The RSHC has been a beneficial addition
□ The traditional syphilis testing alone would suffice
Please explain your answer:
______________________________________________________________________________
______________________________________________________________________________
11. In regard to syphilis testing, what is your opinion about patients’ preferences regarding
having a finger-stick versus having a tube of blood drawn?
□ Patients prefer a finger-stick
□ Patients prefer having a tube of blood drawn
□ Patients have no preference
□ Unsure/don’t know
12. In communicating results of the RSHC test to the patient, what percentage of patients would
you say had issues in understanding what a positive screening test means?
___________________%
13. Would you say this percentage is higher or lower than traditional syphilis testing?
□ Higher than traditional testing
□ Lower than traditional testing
□ About the same as traditional testing
Section C.
When answering the following questions, think of the value of the RSHC as a tool in your
arsenal against the spread of syphilis.
1. As part of the protocol for RSHC testing, a Rapid Syphilis Test Risk Assessment
questionnaire is completed on all clients to determine whether they are at risk for syphilis. Would
you say that this questionnaire adequately provides this information?
□ Yes
□ No
□ Neutral
□Unsure/don’t know
Please explain your answer:
______________________________________________________________________________
______________________________________________________________________________
2. As part of the protocol for RSHC testing, a Rapid Syphilis Test Risk Assessment
questionnaire is completed on all clients to determine whether they have a history of syphilis.
Would you say that this questionnaire adequately provides this information?
□ Yes
□ No
□ Neutral
□Unsure/don’t know
Please explain your answer:
______________________________________________________________________________
Florida Public Health Review, 2019; 16, 106-119.
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______________________________________________________________________________
3. Is the Rapid Syphilis Test Risk Assessment (described in questions 1 and 2 above) helpful, as
it pertains to the effectiveness in identifying new syphilis cases?
□ Yes
□ No
□ Neutral
Please explain your answer:
______________________________________________________________________________
______________________________________________________________________________
4. Were partners of patients with positive RSHC test results notified before the patient got
confirmatory results from traditional syphilis testing?
□ Yes
□ No
□ Unsure/don’t know
If you answered “yes”, did the RSHC test increase the timeliness of partner notification versus
using traditional syphilis testing alone?
□ Yes
□ No
□ Made no difference
□ Unsure/don’t know
5. How likely are you to begin treatment for syphilis based on a positive RSHC test result
(before getting confirmatory test results)? (Check one response only)
□ Highly likely
□ Likely
□ Neutral
□ Unlikely
□ Very unlikely
6. Did positive RSHC test results present more of a challenge to you in how to proceed with
counseling/administering treatment compared to having a positive result from traditional testing?
□ Yes, it presented more of a challenge
□ No, it did not present more of a challenge
□ Neutral, it made no difference either way
Please explain your answer:
______________________________________________________________________________
______________________________________________________________________________
7. Does the RSHC test, with same day results, (versus traditional syphilis testing, with a 3 – 7
day wait time for results) better serve the patient population that receives syphilis testing in
settings other than the health clinic?
□ Yes
□ No
□ Neutral
□ Unsure/don’t know
Please explain your answer:
______________________________________________________________________________
______________________________________________________________________________
8. For syphilis testing in the health clinic, would you prefer to use the RSHC test or traditional
syphilis testing alone?
□ RSHC
□ traditional syphilis testing alone □ No preference
□ Unsure/don’t know
Please explain your answer:
______________________________________________________________________________
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______________________________________________________________________________
9. For syphilis testing in settings other than the health clinic (such as jail or outreach sites),
would you prefer to use the RSHC test or traditional syphilis testing alone?
□ RSHC
□ traditional syphilis testing alone □ No preference
□ Unsure/don’t know
Please explain your answer:
______________________________________________________________________________
______________________________________________________________________________
Section D.
1. List any benefits or positive outcomes that have resulted from the implementation of the
RSHC test in your work setting.
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
2. List any problems or negative outcomes that have resulted from the implementation of the
RSHC test in your work setting.
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
3. Share any other comments about the RSHC test.
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
Thanks for your help!
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